Investigation of optimum N-terminal probrain natriuretic peptide level in patients on maintained hemodialysis

References

• Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: A cross-sectional survey. Lancet. 2012;379:815–822.
   PubMed Web of Science ®Google Scholar
• Wizemann V, Wabel P, Chamney P, et al. The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant. 2009;24:1574–1579.
   PubMed Web of Science ®Google Scholar
• Agarwal R. Hypervolemia is associated with increased mortality among hemodialysis patients. Hypertension. 2010;56:512–517.
   PubMed Web of Science ®Google Scholar
• Paniagua R, Ventura MD, Avila-Díaz M, et al. NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients. Nephrol Dial Transplant. 2010;25:551–557.
   PubMed Web of Science ®Google Scholar
• Hecking M, Karaboyas A, Antlanger M, et al. Significance of interdialytic weight gain versus chronic volume overload: Consensus opinion. Am J Nephrol. 2013;38:78–90.
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Regidor DL, Kovesdy CP, et al. Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation. 2009;119:671–679.
   PubMed Web of Science ®Google Scholar
• Wizemann V, Schilling M. Dilemma of assessing volume state—the use and the limitations of a clinical score. Nephrol Dial Transplant. 1995;10:2114–2117.
   PubMed Web of Science ®Google Scholar
• Braam B, Jindal K, Mees EJD. Hypertension and cardiovascular aspects of dialysis treatment: Clinical management of volume control. vol Book, Whole. Am J Kidney Dis. 2014;64:685–695.
   PubMed Web of Science ®Google Scholar
• Voroneanu L, Cusai C, Hogas S, et al. The relationship between chronic volume overload and elevated blood pressure in hemodialysis patients: Use of bioimpedance provides a different perspective from echocardiography and biomarker methodologies. Int Urol Nephrol. 2010;42:789–797.
   PubMed Web of Science ®Google Scholar
• Shaheen FA, Al Wakeel J, Al-Ghamdi SM, et al. GCC-DOPPS 5 Study Group cardiovascular and cerebrovascular comorbidities in hemodialysis patients from the Gulf Cooperation Council countries enrolled in the dialysis outcome and practice pattern study phase 5 (2012–2015). Saudi J Kidney Dis Transpl. 2016;27:24–30.
   PubMed Web of Science ®Google Scholar
• Ozkahya M, Ok E, Toz H, et al. Long-term survival rates in haemodialysis patients treated with strict volume control. Nephrol Dial Transpl. 2006;21:3506–3513.
   PubMed Web of Science ®Google Scholar
• Papakrivopoulou E, Lillywhite S, Davenport A. Is N-terminal probrain-type natriuretic peptide a clinically useful biomarker of volume overload in peritoneal dialysis patients? Nephrol Dial Transpl. 2012;27:396–401.
   PubMed Web of Science ®Google Scholar
• van de Pol AC, Frenken LA, Moret K, et al. An evaluation of blood volume changes during ultrafiltration pulses and natriuretic peptides in the assessment of dry weight in hemodialysis patients. Hemodial Int. 2007;11:51–61.
   PubMedGoogle Scholar
• Fagugli RM, Palumbo B, Ricciardi D, et al. Association between brain natriuretic peptide and extracellular water in hemodialysis patients. Nephron Clin Pract. 2003;95:c60–c66.
   PubMedGoogle Scholar
• Jacobs LH, van de Kerkhof JJ, Mingels AM, et al. Inflammation, overhydration and cardiac biomarkers in haemodialysis patients: A longitudinal study. Nephrol Dial Transpl. 2010;25:243–248.
   PubMed Web of Science ®Google Scholar
• Booth J, Pinney J, Davenport A. N-terminal proBNP–marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients? Clin J Am Soc Nephrol. 2010;5:1036–1040.
   PubMed Web of Science ®Google Scholar
• Westenbrink BD, Hovinga TK, Kloppenburg WD, Veeger NJ, Janssen WM. B-type natriuretic peptide and interdialytic fluid retention are independent and incremental predictors of mortality in hemodialysis patients. Clin Nephrol. 2011;76:373–379.
   PubMed Web of Science ®Google Scholar
• Kamano C, Osawa H, Hashimoto K, et al. N-terminal pro-brain natriuretic peptide as a predictor of heart failure with preserved ejection fraction in hemodialysis patients without fluid overload. Blood Purif. 2012;33:37–43.
   PubMed Web of Science ®Google Scholar
• Hunt PJ, Yandle TG, Nicholls MG, Richards AM, Espiner EA. The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma. Biochem Biophys Res Commun. 1995;214:1175–1183.
   PubMed Web of Science ®Google Scholar
• Sykes E, Karcher RE, Eisenstadt J, et al. Analytical relationships among Biosite, Bayer, and Roche methods for BNP and NT-proBNP. Am J Clin Pathol. 2005;123:584–590.
   PubMed Web of Science ®Google Scholar
• Levin A, Thompson CR, Ethier J, et al. Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin. Am J Kidney Dis. 1999;34:125–134.
   PubMed Web of Science ®Google Scholar
• Wen CP, Cheng TY, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: A prospective cohort study based on 462 293 adults in Taiwan. Lancet. 2008;28:2173–2182.
   Web of Science ®Google Scholar
• Bednarek-Skublewska A, Zaluska W, Ksiazek A. The relationship between serum level of N-terminal pro-B-type natriuretic peptide and nutritional status, and inflammation in chronic hemodialysis patients. Clin Nephrol. 2010;73:14–20.
   PubMed Web of Science ®Google Scholar
• Tirmenstajn-Jankovic B, Dimkovic N, Perunicic-Pekovic G, et al. Anemia is independently associated with NT-proBNP levels in asymptomatic predialysis patients with chronic kidney disease. Hippokratia. 2013;17:307–312.
   PubMed Web of Science ®Google Scholar
• Knight J, Wong MG, Perkovic V. Optimal targets for blood pressure control in chronic kidney disease: The debate continues. Curr Opin Nephrol Hypertens. 2014;23:541.
   PubMed Web of Science ®Google Scholar
• Mancini A. Hypotension and frequent hemodialysis: Clarification requested regarding the KDOQI hemodialysis adequacy guideline 2015 update. Am J Kidney Dis. 2016;67:532.
   PubMed Web of Science ®Google Scholar
• Kidney Disease. Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO clinical practice guideline for Anemia in chronic kidney disease. Kidney Int Suppl. 2012;2:279–335.
   Google Scholar
• Ruperti Repilado FJ, Aeschbacher S, Bossard M, et al. Relationship of N-terminal fragment of Pro-B-Type Natriuretic Peptide and copeptin with erythrocytes-related parameters: A population-based study. Clin Biochem. 2016;49:651–666.
   PubMed Web of Science ®Google Scholar
• Januzzi JL, van Kimmenade R, Lainchbury J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an internationalpooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J. 2006;27:330–337.
   PubMed Web of Science ®Google Scholar
• Ludka O, Spinar J, Tomandl J, Konecny T. Comparison of NT-proBNP levels in hemodialysis versus peritoneal dialysis patients. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013;157:325–330.
   PubMed Web of Science ®Google Scholar